“…It has been implicated in the migration of neural crest cells (Akitaya and Bronner-Fraser, 1992), neurite outgrowth (Doherty and Walsh, 1992), axonal fasciculation (Cremer et al, 1997), myelination (Palser et al, 2009), molecular organisation and modulation of synapses (Kiss and Muller, 2001) and myogenesis (Knudsen et al, 1990). NCAM interacts with other NCAM molecules on adjacent cells, as well with fibroblast growth factor receptor (FGFR) (Povlsen et al, 2003), adhesion molecule L1 (Horstkorte et al, 1993), ATP (Hubschmann and Skladchikova), glial cell line-derived neurotrophic factor (GDNF) (Cao et al, 2008), prion protein (PrP) (Schmitt-Ulms et al, 2001), TAG-1/axonin-1 (Milev et al, 1996), glucocorticoid receptor (Crossin et al, 1997), brain-derived neurotrophic factor (BDNF) (Vutskits et al, 2001), platelet-derived growth factor (PDGF) (Zhang et al, 2004) and extracellular matrix components, in particular chondroitin sulphate proteoglycans and heparin sulphate proteoglycans (Kallapur and Akeson, 1992). In most instances, the interaction is mediated via the N-terminal Ig-like domains.…”